173 related articles for article (PubMed ID: 33051224)
1. Long-term Outcomes of Individuals With Metabolic Diseases Identified Through Newborn Screening.
Mütze U; Garbade SF; Gramer G; Lindner M; Freisinger P; Grünert SC; Hennermann J; Ensenauer R; Thimm E; Zirnbauer J; Leichsenring M; Gleich F; Hörster F; Grohmann-Held K; Boy N; Fang-Hoffmann J; Burgard P; Walter M; Hoffmann GF; Kölker S
Pediatrics; 2020 Nov; 146(5):. PubMed ID: 33051224
[TBL] [Abstract][Full Text] [Related]
2. Newborn screening and disease variants predict neurological outcome in isovaleric aciduria.
Mütze U; Henze L; Gleich F; Lindner M; Grünert SC; Spiekerkoetter U; Santer R; Blessing H; Thimm E; Ensenauer R; Weigel J; Beblo S; Arélin M; Hennermann JB; Marquardt T; Marquardt I; Freisinger P; Krämer J; Dieckmann A; Weinhold N; Keller M; Walter M; Schiergens KA; Maier EM; Hoffmann GF; Garbade SF; Kölker S
J Inherit Metab Dis; 2021 Jul; 44(4):857-870. PubMed ID: 33496032
[TBL] [Abstract][Full Text] [Related]
3. Long-term anthropometric development of individuals with inherited metabolic diseases identified by newborn screening.
Mütze U; Garbade SF; Gleich F; Lindner M; Freisinger P; Hennermann JB; Thimm E; Gramer G; Posset R; Krämer J; Grünert SC; Hoffmann GF; Kölker S
J Inherit Metab Dis; 2023 Jan; 46(1):15-27. PubMed ID: 36134599
[TBL] [Abstract][Full Text] [Related]
4. Diagnostic contribution of metabolic workup for neonatal inherited metabolic disorders in the absence of expanded newborn screening.
Bower A; Imbard A; Benoist JF; Pichard S; Rigal O; Baud O; Schiff M
Sci Rep; 2019 Oct; 9(1):14098. PubMed ID: 31575911
[TBL] [Abstract][Full Text] [Related]
5. A Population-Based Genomic Study of Inherited Metabolic Diseases Detected Through Newborn Screening.
Park KJ; Park S; Lee E; Park JH; Park JH; Park HD; Lee SY; Kim JW
Ann Lab Med; 2016 Nov; 36(6):561-72. PubMed ID: 27578510
[TBL] [Abstract][Full Text] [Related]
6. Severity-adjusted evaluation of newborn screening on the metabolic disease course in individuals with cytosolic urea cycle disorders.
Posset R; Kölker S; Gleich F; Okun JG; Gropman AL; Nagamani SCS; Scharre S; Probst J; Walter ME; Hoffmann GF; Garbade SF; Zielonka M;
Mol Genet Metab; 2020 Dec; 131(4):390-397. PubMed ID: 33288448
[TBL] [Abstract][Full Text] [Related]
7. Newborn screening for inherited metabolic diseases using tandem mass spectrometry in China: Outcome and cost-utility analysis.
Zhao Z; Chen C; Sun X; Zhou D; Huang X; Dong H
J Med Screen; 2022 Mar; 29(1):12-20. PubMed ID: 34102920
[TBL] [Abstract][Full Text] [Related]
8. [Evaluation and optimization of newborn screening by structured long-term follow-up-using the example of inherited metabolic diseases].
Mütze U; Kölker S
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2023 Nov; 66(11):1249-1258. PubMed ID: 37815612
[TBL] [Abstract][Full Text] [Related]
9. Development of newborn screening connect (NBS connect): a self-reported patient registry and its role in improvement of care for patients with inherited metabolic disorders.
Osara Y; Coakley K; Devarajan A; Singh RH
Orphanet J Rare Dis; 2017 Jul; 12(1):132. PubMed ID: 28724394
[TBL] [Abstract][Full Text] [Related]
10. Challenges for Worldwide Harmonization of Newborn Screening Programs.
Martínez-Morillo E; Prieto García B; Álvarez Menéndez FV
Clin Chem; 2016 May; 62(5):689-98. PubMed ID: 27001491
[TBL] [Abstract][Full Text] [Related]
11. Neonatal Screening for Inherited Metabolic Diseases in 2016.
Villoria JG; Pajares S; López RM; Marin JL; Ribes A
Semin Pediatr Neurol; 2016 Nov; 23(4):257-272. PubMed ID: 28284388
[TBL] [Abstract][Full Text] [Related]
12. A framework for assessing outcomes from newborn screening: on the road to measuring its promise.
Hinton CF; Homer CJ; Thompson AA; Williams A; Hassell KL; Feuchtbaum L; Berry SA; Comeau AM; Therrell BL; Brower A; Harris KB; Brown C; Monaco J; Ostrander RJ; Zuckerman AE; Kaye C; Dougherty D; Greene C; Green NS;
Mol Genet Metab; 2016 Aug; 118(4):221-9. PubMed ID: 27268406
[TBL] [Abstract][Full Text] [Related]
13. Using Informatics to Build a Digital Health Footprint of Patients Living With Inherited Metabolic Disorders Identified by Newborn Screening.
Singh RH; Brown SJ; Hale PM; Narlow K; Gurung S; Salvatore ML; Tchamako JK
J Public Health Manag Pract; 2022 Mar-Apr 01; 28(2):E340-E344. PubMed ID: 33208722
[TBL] [Abstract][Full Text] [Related]
14. Long-term follow-up study of patients with phenylketonuria detected by the newborn screening programme in Japan.
Aoki K; Ohwada M; Kitagawa T
J Inherit Metab Dis; 2007 Aug; 30(4):608. PubMed ID: 17641826
[TBL] [Abstract][Full Text] [Related]
15. Inherited metabolic disorders in the neonatal intensive care unit: Red flags to look out for.
Eminoğlu FT; Koç Yekedüz M; Doğulu N; Öncül Ü; Köse E; Okulu E; Erdeve Ö; Atasay B; Arsan S
Pediatr Int; 2022 Jan; 64(1):e14953. PubMed ID: 34390086
[TBL] [Abstract][Full Text] [Related]
16. Progress of newborn screening in China.
Jiang H; Yang R; Dong A; Wu B; Zhao Z
Zhejiang Da Xue Xue Bao Yi Xue Ban; 2023 Dec; 52(6):673-682. PubMed ID: 38115737
[TBL] [Abstract][Full Text] [Related]
17. Application of a Novel Algorithm for Expanding Newborn Screening for Inherited Metabolic Disorders across Europe.
Jones SA; Cheillan D; Chakrapani A; Church HJ; Heales S; Wu THY; Morton G; Roberts P; Sluys EF; Burlina A
Int J Neonatal Screen; 2022 Mar; 8(1):. PubMed ID: 35323199
[TBL] [Abstract][Full Text] [Related]
18. Newborn screening in southeastern Europe.
Groselj U; Tansek MZ; Smon A; Angelkova N; Anton D; Baric I; Djordjevic M; Grimci L; Ivanova M; Kadam A; Kotori VM; Maksic H; Marginean O; Margineanu O; Milijanovic O; Moldovanu F; Muresan M; Murko S; Nanu M; Lampret BR; Samardzic M; Sarnavka V; Savov A; Stojiljkovic M; Suzic B; Tincheva R; Tahirovic H; Toromanovic A; Usurelu N; Battelino T
Mol Genet Metab; 2014; 113(1-2):42-5. PubMed ID: 25174966
[TBL] [Abstract][Full Text] [Related]
19. The Role of Technology in Newborn Screening.
Millington DS
N C Med J; 2019; 80(1):49-53. PubMed ID: 30622207
[TBL] [Abstract][Full Text] [Related]
20. Chinese expert brief consensus on newborn screening of inherited metabolic disorders during the novel coronavirus infection epidemic.
Liu S; Wang D; Wan K; Liu H; Zhang D; Yang J; Yuan Z; He X; Wang J; Ou M; Zhu W; Qu Y; Zhao D; Wang W; Liu S; Gu M; Huang S; Wang Z; Zou L
Ann Transl Med; 2020 Apr; 8(7):429. PubMed ID: 32395473
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
